Company profile
ARC Regulatory Consulting
ARC is a niche provider of global regulatory and clinical research solutions to the precision medicine and in vitro diagnostic medical device industry. ARC is a trusted partner in the global ambition to improve patient care, leveraging our expertise in delivering high quality, accelerated clinical research for biomarker diagnostics.
Updated 06 Jun 2026 16:52
Financial period: 1 Feb 2024 to 31 Jan 2025
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
AD01 | Transaction MzQzOTA3NjE5M2FkaXF6a2N4
Published 10 Oct 2024 04:41
Company registered at Companies House
1 Nov 2024 to 31 Oct 2027
To develop a Regulatory Navigator software platform for the Precision Medicine / In Vitro Diagnostics Industry to assist clinical trial Sponsors in accessing in real-time, accurate information on global regulatory requirements and understanding the implications for their clinical development pipelines
1 Oct 2024 to 31 Mar 2025
In Vitro Diagnostics (IVDs) are an essential element of Precision Medicine. When a new drug is being developed for a condition such as cancer, an IVD is often required in order to support the selection of the most appropriate clinical trial subjects, and/or as a measure of the effectiveness of the drug. Driven by global regulatory authority regulations, t...
